€0.09
(9.68%)
Add to watchlist
Create an alert
Stocks and Shares ISABiosynex SA is a France-based company that specializes in the research, development and manufacture of in-vitro diagnostic kits aimed at health professionals. The Company’s products are used by biological and analytical services laboratories, obstetric units and emergency units, as well as in medical resource-limited settings. Biosynex SA specializes in four fields: tropical diseases, emergency markers, infectious diseases and autoimmunity. The Company’s products include Amnioquick (Obstetrics); Immunoquick Malaria Falciparum and Immunoquick Malaria +4 (Parasitology); Immunoquick Elifa HSV IGG, Immunoquick Elifa EBV G and Immunoquick Mono (Virology); Immunoquick Filtration CELIAC IgA and Immunoquick TG (Autoimmunology); and Immunoquick Tetanus (Bacteriology). It operates through Fumouze Diagnostics and SR2B.
Company Information
About this company
Key people
Larry Abensur
Chairman of the Board, Chief Executive Officer
Thomas Lamy
Deputy Chief Executive Officer, Director
Thierry Paper
Deputy Chief Executive Officer - Research and Business Development, Director
Diane Abensur Bessin
Director
Elie Fraenckel
Director
Brigitte Geny
Director
Click to see more
Key facts
- Shares in issue18.75m
- EPICALBIO
- ISINFR0011005933
- LocationFrance
- SectorHealthcare
- IndustryBiotechnology & Drugs
- Market cap€17.44m
- Employees486
- ExchangeEuronext Paris
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.